FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
On eve of Alzheimer’s drug decision, Congress critiques FDA for Aduhelm review failures
By
Alicia Lasek
Jan 03, 2023
An “atypical review process and corporate greed” factored into the FDA’s approval of Alzheimer’s drug Aduhelm in 2021, congressional investigators say. They recommend sticking to protocol...
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.
Dementia toolkit for clinicians underscores urgency of early diagnosis
By
Alicia Lasek
Mar 31, 2021
A primary care toolkit for brain health assessment and dementia diagnosis has gotten a much-needed update as more research points to the potential for better outcomes with earlier diagnoses, the authors...
LTC docs push for more training, competency requirements for medical directors
By
Alicia Lasek
Apr 11, 2022
It’s time for Congress and CMS to take action and raise the profile and competencies of industry clinicians — especially medical directors, according to long-term care physician advocate AMDA.
Cannabis-related issues sending more seniors to the ED, study finds
By
Alicia Lasek
Jan 12, 2023
Cannabis-related ED visits for older adults shot up by a whopping 1,800% between 2005 to 2019 in California, investigators say. The state’s experience mirrors national trends.
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Sodium selenate found safe in early trial targeting frontotemporal dementia
By
Alicia Lasek
May 18, 2023
An early-stage study has found that sodium selenate is safe and well-tolerated in patients with behavioral variant frontotemporal dementia.
Preventable diseases tied to common, age-related eye condition, study finds
By
Alicia Lasek
Jan 11, 2023
Age-related macular degeneration is linked to two potentially treatable diseases, suggesting new pathways for preventing progression and blindness, investigators say.